|
1. J&J acquires immune disease biologics company for $850M Full story
2. Teva launches first generic GLP-1 Full story
3. Eli Lilly hits phony drugmakers with 6 more lawsuits Full story
4. Added ASC-covered procedures ramps up volume + complexity in RCM. Help teams address rising challenges with tips here.
5. Ozempic maker plans $4.1B manufacturing plant Full story
6. Cancer therapy trials paused after 2 deaths Full story
7. Some CNOs are gaining control over staffing costs with data. The tools informing better workforce decisions: here.
8. 5 drugs now in shortage Full story
Becker's Learning Opportunity - Access In One Click
9. Learning Opportunity: Hospital pharmacies may be overlooking savings potential by focusing on drug prices alone. Get an approach to capture more savings, here.
10. Learning Opportunity: AI governance' isn't just a buzzword — it's critical to realize any value from the technology. Leaders sum it all up, here.
11. Learning Opportunity: UCLA Health is embracing a data-driven marketing strategy — see the benefits here.
|
.png)
